Freda Lewis-Hall, MD, DFAPA, MFPM

Dr. Freda Lewis-Hall is a pioneer in medicine, having spent more than 40 years on the frontlines of healthcare as a clinician, researcher, and leader in the biopharmaceutical and life sciences industries. Most recently, at Pfizer, Inc, she served more than ten years on the executive leadership team as executive vice president, chief medical officer, and later chief patient officer. Her tenure at Pfizer was devoted to ensuring the safe, effective, and appropriate use of medicines and vaccines produced by the pharmaceutical giant, from the first clinical trial to its last use. Prior to joining Pfizer, Dr. Lewis-Hall held senior leadership roles at Vertex Pharmaceuticals, Bristol-Myers Squibb, Pharmacia Corporation, and Eli Lilly and Company. She has also held positions in the National Institute of Mental Health and the Department of Psychiatry at her alma mater Howard University College of Medicine and recently completed a decade of service on the inaugural Board of Governors for the Patient-Centered Outcomes Research Institute (PCORI). Dr. Lewis-Hall serves on the Boards of the Foundation of the National Institutes of Health, The Milken Institute’s FasterCures Center, the Prostate Cancer Foundation, the Davos Alzheimer’s Collaborative, and the Dalio Center for Health Justice at NewYork-Presbyterian. She also serves on the corporate boards of Milliken and Company, a global diversified industrial manufacturer; 1Life Healthcare, Inc., a health services company; Exact Sciences, Inc., a molecular diagnostics company; and SpringWorks Therapeutics, a biopharmaceutical company. She is a member of the Board of Fellows of The Harvard Medical School, and the Board of Advisors of the Dell Medical School.